Why the study?
Does a 24-h course of levosimendan improve systolic myocardial velocity and exercise capacity in patients with decompensated heart failure?
Does a 24-h course of levosimendan improve systolic myocardial velocity and exercise capacity in patients with decompensated heart failure?
A 24-hour course of levosimendan significantly improves systolic myocardial velocity and exercise capacity in patients with decompensated heart failure.
No takes yet. Share an insight, caveat, or question.
May enhance Sm and exercise capacity in decompensated HF; leaves open effects on clinical outcomes.
Kasikcioglu et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: